COVID-19 mRNA vaccine that uses fundamental Penn technology receives FDA approval Katalin Karikó, an adjunct professor of Neurosurgery at Penn and a senior vice president at BioNTech, and Drew Weissman, the Roberts Family Professor in Vaccine Research. (Image: Penn Medicine News) COVID-19 mRNA vaccine that uses fundamental Penn technology receives FDA approval Pfizer/BioNTech’s vaccine to prevent COVID-19 uses fundamental modified mRNA technology created by Drew Weissman and Katalin Karikó at the Perelman School of Medicine.
The F.D.A. grants full approval to the Pfizer-BioNTech Covid-19 vaccine The New York Times The F.D.A. grants full approval to the Pfizer-BioNTech Covid-19 vaccine Alison Buttenheim of the School of Nursing is quoted on the rates of vaccine hesitancy despite FDA vaccine approval. Have you already had a breakthrough COVID infection? The New Yorker Have you already had a breakthrough COVID infection? Jeffrey Morris of the Perelman School of Medicine says the efficacy rate of vaccines are actually higher than reported. Penn study details robust T-cell response to mRNA COVID-19 vaccines Penn study details robust T-cell response to mRNA COVID-19 vaccines The results underline the importance of a second dose and include implications for booster shots. Engineers create faster and cheaper COVID-19 testing with pencil lead César de la Fuente, Presidential Assistant Professor Engineers create faster and cheaper COVID-19 testing with pencil lead A new electrochemical COVID-19 test addresses the challenges of cost, time, and accuracy and uses electrodes made from graphite. Delta-plus and lambda variants don’t yet warrant panic for vaccinated people, Philly experts say Philadelphia Inquirer Delta-plus and lambda variants don’t yet warrant panic for vaccinated people, Philly experts say Frederic Bushman of the Perelman School of Medicine spoke about new COVID-19 variants and said his team has not yet seen the “delta-plus” or lambda variants in the Philadelphia-area samples they’ve analyzed. COVID-19 transmission rates move into substantial range across majority of tri-state region CBS Philadelphia COVID-19 transmission rates move into substantial range across majority of tri-state region Frederic Bushman of the Perelman School of Medicine said the majority of COVID samples processed by his lab are of the delta variant. “We’ve been a little behind other places in the U.S, but now it’s here,” he said. Penn researching ways to avoid side effects of key treatment for serious COVID cases WHYY (Philadelphia) Penn researching ways to avoid side effects of key treatment for serious COVID cases To improve outcomes for patients hospitalized with COVID-19, researchers led by Mitchell Lazar of the Perelman School of Medicine are exploring which populations are most prone to side effects when treated with glucocorticoids, a type of steroid. A COVID vaccine for kids A COVID vaccine for kids Jeff Gerber, who is heading the clinical trial of the Moderna vaccine in kids under 12 at CHOP, speaks with Penn Today about the trial and why getting children vaccinated is so essential. There are few good COVID antivirals, but that could be changing Scientific American There are few good COVID antivirals, but that could be changing Sara Cherry of the Perelman School of Medicine spoke about the arduous process of developing antiviral drugs to treat COVID-19. “Most of the compounds that work in cells ultimately fail in animal studies for lots of reasons,” she said. Of the compounds that remain, just a few make it to the animal testing stage. Load More
Have you already had a breakthrough COVID infection? The New Yorker Have you already had a breakthrough COVID infection? Jeffrey Morris of the Perelman School of Medicine says the efficacy rate of vaccines are actually higher than reported. Penn study details robust T-cell response to mRNA COVID-19 vaccines Penn study details robust T-cell response to mRNA COVID-19 vaccines The results underline the importance of a second dose and include implications for booster shots. Engineers create faster and cheaper COVID-19 testing with pencil lead César de la Fuente, Presidential Assistant Professor Engineers create faster and cheaper COVID-19 testing with pencil lead A new electrochemical COVID-19 test addresses the challenges of cost, time, and accuracy and uses electrodes made from graphite. Delta-plus and lambda variants don’t yet warrant panic for vaccinated people, Philly experts say Philadelphia Inquirer Delta-plus and lambda variants don’t yet warrant panic for vaccinated people, Philly experts say Frederic Bushman of the Perelman School of Medicine spoke about new COVID-19 variants and said his team has not yet seen the “delta-plus” or lambda variants in the Philadelphia-area samples they’ve analyzed. COVID-19 transmission rates move into substantial range across majority of tri-state region CBS Philadelphia COVID-19 transmission rates move into substantial range across majority of tri-state region Frederic Bushman of the Perelman School of Medicine said the majority of COVID samples processed by his lab are of the delta variant. “We’ve been a little behind other places in the U.S, but now it’s here,” he said. Penn researching ways to avoid side effects of key treatment for serious COVID cases WHYY (Philadelphia) Penn researching ways to avoid side effects of key treatment for serious COVID cases To improve outcomes for patients hospitalized with COVID-19, researchers led by Mitchell Lazar of the Perelman School of Medicine are exploring which populations are most prone to side effects when treated with glucocorticoids, a type of steroid. A COVID vaccine for kids A COVID vaccine for kids Jeff Gerber, who is heading the clinical trial of the Moderna vaccine in kids under 12 at CHOP, speaks with Penn Today about the trial and why getting children vaccinated is so essential. There are few good COVID antivirals, but that could be changing Scientific American There are few good COVID antivirals, but that could be changing Sara Cherry of the Perelman School of Medicine spoke about the arduous process of developing antiviral drugs to treat COVID-19. “Most of the compounds that work in cells ultimately fail in animal studies for lots of reasons,” she said. Of the compounds that remain, just a few make it to the animal testing stage. Load More
Penn study details robust T-cell response to mRNA COVID-19 vaccines Penn study details robust T-cell response to mRNA COVID-19 vaccines The results underline the importance of a second dose and include implications for booster shots.
Engineers create faster and cheaper COVID-19 testing with pencil lead César de la Fuente, Presidential Assistant Professor Engineers create faster and cheaper COVID-19 testing with pencil lead A new electrochemical COVID-19 test addresses the challenges of cost, time, and accuracy and uses electrodes made from graphite.
Delta-plus and lambda variants don’t yet warrant panic for vaccinated people, Philly experts say Philadelphia Inquirer Delta-plus and lambda variants don’t yet warrant panic for vaccinated people, Philly experts say Frederic Bushman of the Perelman School of Medicine spoke about new COVID-19 variants and said his team has not yet seen the “delta-plus” or lambda variants in the Philadelphia-area samples they’ve analyzed. COVID-19 transmission rates move into substantial range across majority of tri-state region CBS Philadelphia COVID-19 transmission rates move into substantial range across majority of tri-state region Frederic Bushman of the Perelman School of Medicine said the majority of COVID samples processed by his lab are of the delta variant. “We’ve been a little behind other places in the U.S, but now it’s here,” he said. Penn researching ways to avoid side effects of key treatment for serious COVID cases WHYY (Philadelphia) Penn researching ways to avoid side effects of key treatment for serious COVID cases To improve outcomes for patients hospitalized with COVID-19, researchers led by Mitchell Lazar of the Perelman School of Medicine are exploring which populations are most prone to side effects when treated with glucocorticoids, a type of steroid. A COVID vaccine for kids A COVID vaccine for kids Jeff Gerber, who is heading the clinical trial of the Moderna vaccine in kids under 12 at CHOP, speaks with Penn Today about the trial and why getting children vaccinated is so essential. There are few good COVID antivirals, but that could be changing Scientific American There are few good COVID antivirals, but that could be changing Sara Cherry of the Perelman School of Medicine spoke about the arduous process of developing antiviral drugs to treat COVID-19. “Most of the compounds that work in cells ultimately fail in animal studies for lots of reasons,” she said. Of the compounds that remain, just a few make it to the animal testing stage. Load More
COVID-19 transmission rates move into substantial range across majority of tri-state region CBS Philadelphia COVID-19 transmission rates move into substantial range across majority of tri-state region Frederic Bushman of the Perelman School of Medicine said the majority of COVID samples processed by his lab are of the delta variant. “We’ve been a little behind other places in the U.S, but now it’s here,” he said. Penn researching ways to avoid side effects of key treatment for serious COVID cases WHYY (Philadelphia) Penn researching ways to avoid side effects of key treatment for serious COVID cases To improve outcomes for patients hospitalized with COVID-19, researchers led by Mitchell Lazar of the Perelman School of Medicine are exploring which populations are most prone to side effects when treated with glucocorticoids, a type of steroid. A COVID vaccine for kids A COVID vaccine for kids Jeff Gerber, who is heading the clinical trial of the Moderna vaccine in kids under 12 at CHOP, speaks with Penn Today about the trial and why getting children vaccinated is so essential. There are few good COVID antivirals, but that could be changing Scientific American There are few good COVID antivirals, but that could be changing Sara Cherry of the Perelman School of Medicine spoke about the arduous process of developing antiviral drugs to treat COVID-19. “Most of the compounds that work in cells ultimately fail in animal studies for lots of reasons,” she said. Of the compounds that remain, just a few make it to the animal testing stage. Load More
Penn researching ways to avoid side effects of key treatment for serious COVID cases WHYY (Philadelphia) Penn researching ways to avoid side effects of key treatment for serious COVID cases To improve outcomes for patients hospitalized with COVID-19, researchers led by Mitchell Lazar of the Perelman School of Medicine are exploring which populations are most prone to side effects when treated with glucocorticoids, a type of steroid. A COVID vaccine for kids A COVID vaccine for kids Jeff Gerber, who is heading the clinical trial of the Moderna vaccine in kids under 12 at CHOP, speaks with Penn Today about the trial and why getting children vaccinated is so essential. There are few good COVID antivirals, but that could be changing Scientific American There are few good COVID antivirals, but that could be changing Sara Cherry of the Perelman School of Medicine spoke about the arduous process of developing antiviral drugs to treat COVID-19. “Most of the compounds that work in cells ultimately fail in animal studies for lots of reasons,” she said. Of the compounds that remain, just a few make it to the animal testing stage. Load More
A COVID vaccine for kids A COVID vaccine for kids Jeff Gerber, who is heading the clinical trial of the Moderna vaccine in kids under 12 at CHOP, speaks with Penn Today about the trial and why getting children vaccinated is so essential.
There are few good COVID antivirals, but that could be changing Scientific American There are few good COVID antivirals, but that could be changing Sara Cherry of the Perelman School of Medicine spoke about the arduous process of developing antiviral drugs to treat COVID-19. “Most of the compounds that work in cells ultimately fail in animal studies for lots of reasons,” she said. Of the compounds that remain, just a few make it to the animal testing stage.